Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FBXO22 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA531014
Description
Recommended positive controls: A549, HepG2. Predicted reactivity: Mouse (92%), Rat (92%), Rhesus Monkey (98%), Bovine (90%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Two transcript variants encoding different isoforms exist for this gene.
Specifications
FBXO22 | |
Polyclonal | |
Unconjugated | |
FBXO22 | |
0610033L19Rik; 1600016C16Rik; F-box only protein 22; F-box protein 22; F-box protein FBX22p44; Fbx22; Fbxo22; FIST domain containing 1; FISTC1 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
26263 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.29 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
Q8NEZ5 | |
FBXO22 | |
Recombinant fragment corresponding to a region within amino acids 167 and 403 of Human FBXO22. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction